As the global economy mends, the 2021 growth of Melbine will have significant change from previous year. According to our (LP Information) latest study, the global Melbine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Melbine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Melbine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Melbine market, reaching US$ million by the year 2028. As for the Europe Melbine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Melbine players cover Xi'an ruixi Biological Technological Co.L, Sino-american Shanghai Squibb Pharmaceutical Co. LTD, Shenzhen Zhonglian Pharmaceutical Co., Ltd., and Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Melbine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Sustained Release Tablet
Enteric Coatel Tablets
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Medicine
Chemistry
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Xi'an ruixi Biological Technological Co.L
Sino-american Shanghai Squibb Pharmaceutical Co. LTD
Shenzhen Zhonglian Pharmaceutical Co., Ltd.
Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd
Shijiazhuang Xinhua Pharmaceutical Co., Ltd.
Beijing Liling Hengtai Drug Co., Ltd.
AstraZeneca
MIMS
Chengdu Hengrui Pharmaceutical
Merck Healthcare KGaA
Shandong Sibang Pharmaceutical Co. LTD
Hebei Samshi Pharmaceutical Co. LTD
Yuekang Pharmaceutical Group Co. LTD
Qingdao Huanghai Pharmaceutical Co. LTD
Guizhou Tian 'an Pharmaceutical Co. LTD
Summary:
Get latest Market Research Reports on Melbine. Industry analysis & Market Report on Melbine is a syndicated market report, published as Global Melbine Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Melbine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.